Over 1,400 IEMs have been identified, with the remaining untreatable and their underlying mechanisms yet to be fully elucidated [1,2,3,4]
10.3389/fphar.2025.1589751 Front
immediate labs if new medications are added or symptoms develop If ALT/AST rise above 2x upper limit of normal: Hold both agents, investigate, and reintroduce one at a time after normalization This schedule is conservative
This blend comes in lyophilized (powder) form, which keeps it stable during shipping
Gomisin N isolated from Schisandra chinensis significantly induces anti-proliferative and pro-apoptotic effects in hepatic carcinoma
Expected timeline: Month 1-2: Inflammation management, symptomatic improvement Month 3-6: Potential slowing of degenerative markers, quality of life improvement Month 6-12: Assessment of structural changes, protocol optimization Ongoing: Maintenance protocols as needed, cycling strategies Complementary approaches: Anti-inflammatory nutrition